Literature DB >> 18637116

Understanding the concept of chemotherapy-related nausea: the patient experience.

A Molassiotis1, C T Stricker, B Eaby, L Velders, P A Coventry.   

Abstract

The aim of this study was to explore the experience of chemotherapy-related nausea in patients with cancer. A qualitative study was carried out with 17 patients who had experienced nausea during their chemotherapy in the UK and USA. Nausea was described as distressing and complex symptom. Patients attempted to construct an understanding of nausea using cognitive processes such as analysing their experience of nausea and related symptoms, attributing causation to nausea and comparing their experiences not only to their own expectations, but also to others' symptom experiences. A number of concurrent and associated symptoms linked with nausea were identified. Preliminary evidence emerged for nausea as part of a cluster of symptoms. Anti-emetic medication, provider-directed management strategies and self-management strategies were used by patients to minimize the effects of nausea. Self-management techniques, such as dietary strategies, were rooted in participants' understanding of nausea and their beliefs about what caused nausea, and there was little evidence of guidance from professionals beyond advice about medication management. This study reveals some of the complexities behind chemotherapy-induced nausea, including a potential symptom cluster, and contributes towards a clearer understanding of this symptom and its effects on patients' lives.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18637116     DOI: 10.1111/j.1365-2354.2007.00872.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  20 in total

Review 1.  Qualitative research into the symptom experiences of adult cancer patients after treatments: a systematic review and meta-synthesis.

Authors:  A E Bennion; A Molassiotis
Journal:  Support Care Cancer       Date:  2012-09-13       Impact factor: 3.603

2.  Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries.

Authors:  Ruey Kuen Hsieh; Alexandre Chan; Hoon-Kyo Kim; Shiying Yu; Jong Gwang Kim; Myung-Ah Lee; Johan Dalén; Hun Jung; Yan Ping Liu; Thomas A Burke; Dorothy M K Keefe
Journal:  Support Care Cancer       Date:  2014-08-14       Impact factor: 3.603

3.  Use of antiemetics in the management of chemotherapy-related nausea and vomiting in current UK practice.

Authors:  Alexander Molassiotis; Sarah G Brearley; Zoe Stamataki
Journal:  Support Care Cancer       Date:  2010-06-24       Impact factor: 3.603

4.  Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy.

Authors:  I N Olver; P Grimison; M Chatfield; M R Stockler; G C Toner; V Gebski; R Harrup; C Underhill; G Kichenadasse; N Singhal; I D Davis; A Boland; A McDonald; D Thomson
Journal:  Support Care Cancer       Date:  2012-12-30       Impact factor: 3.603

5.  Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster.

Authors:  Carlo Pirri; Evan Bayliss; James Trotter; Ian N Olver; Paul Katris; Peter Drummond; Robert Bennett
Journal:  Support Care Cancer       Date:  2012-09-14       Impact factor: 3.603

6.  Network Analysis of the Multidimensional Symptom Experience of Oncology.

Authors:  Nikolaos Papachristou; Payam Barnaghi; Bruce Cooper; Kord M Kober; Roma Maguire; Steven M Paul; Marilyn Hammer; Fay Wright; Jo Armes; Eileen P Furlong; Lisa McCann; Yvette P Conley; Elisabeth Patiraki; Stylianos Katsaragakis; Jon D Levine; Christine Miaskowski
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

7.  A qualitative study investigating chemotherapy-induced nausea as a symptom cluster.

Authors:  Ian N Olver; Jaklin A Eliott; Bogda Koczwara
Journal:  Support Care Cancer       Date:  2014-05-08       Impact factor: 3.603

8.  Text Messaging (SMS) Helping Cancer Care in Patients Undergoing Chemotherapy Treatment: a Pilot Study.

Authors:  Timóteo Matthies Rico; Karina Dos Santos Machado; Vanessa Pellegrini Fernandes; Samanta Winck Madruga; Patrícia Tuerlinckx Noguez; Camila Rose Guadalupe Barcelos; Mateus Madail Santin; Cristiane Rios Petrarca; Samuel Carvalho Dumith
Journal:  J Med Syst       Date:  2017-10-09       Impact factor: 4.460

9.  Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis.

Authors:  Masato Karayama; Naoki Inui; Kazuki Tanaka; Hideki Yasui; Hironao Hozumi; Yuzo Suzuki; Kazuki Furuhashi; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Takafumi Suda
Journal:  Med Oncol       Date:  2018-09-05       Impact factor: 3.064

10.  Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting.

Authors:  A Molassiotis; Z Stamataki; E Kontopantelis
Journal:  Support Care Cancer       Date:  2013-05-30       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.